Publication
We're building the world's most powerful platform for genetic discovery.
The 23andMe Research Institute is a nonprofit organization dedicated to using the world's largest recontactable genetics cohort to accelerate breakthroughs in science that benefit all of mankind. By making that data available to researchers, partners and the scientific community, we can fuel even greater discovery and impact together.
Our Vision
Uniting people everywhere under the common goal of improving health and deepening our understanding of DNA, the code of life.
Our Research Mission
To help people access, understand and benefit from the human genome - through participant-powered research that is accessible, ethical and rigorous.
The world's largest and most diverse genetics research cohort.
The scale to ask big questions. The diversity to make the answers matter to everyone.
- 11M+Research-consented genotyped participants
- >80%Members opt in to participate in research
- 8,400,000 European
- 1,725,000 Latine
- 604,000 African
- 395,000 East Asian
- 110,000 South Asian
- 655,000 Other
“Most genetics research has been built on a narrow slice of humanity. Our diversity enables us to make discoveries that help everyone benefit from the human genome.”
Community-powered research is rewriting what we know about human health.
Publication
Large-scale analysis demonstrates the influence of CYP2C19 genotype on specific SSRI side effects
Deep on genetics. Rich across every dimension of health.
Our data set isn't just genetics. It's a multi-dimensional picture of human health, linking genetic data to the full range of factors that shape how our genes play out in real life.
- Genetic
- Phenotypic (self-reported data)
- Health Records
- Wearables & lifestyle
One cohort.
Every scale of disease.
No condition is too common — or too rare — to study here.
| Condition | Cohort size |
|---|---|
| Obesity | 2.3M |
| Asthma | 1.3M |
| Coronary Artery Disease | 194k |
| Breast cancer | 127k |
| Parkinson’s | 35k |
| Liver cirrhosis | 20k |
| Sarcoidosis | 10k |
- 300+Peer-reviewed publications in Nature Genetics, NEJM and other leading journals
- 1,500+Genetic discoveries made across hundreds of conditions and traits
- 1,000+Disease and condition cohorts studied
Our approach
The world's
largest and most
diverse genetics research cohort.
Open, collaborative and relentless in pursuit of discovery.
- See publications
Internal Research
Our scientists design and run studies across 1,000+ disease areas, publishing findings in top peer-reviewed journals.
- Learn more
External Collaborations
We team up with experts across industry and academia to accelerate discoveries that would take any one organization far longer to reach alone.
Partnering
for impact
We work with
- Academic Institutions
- BioPharma Companies
- Health Tech Companies
- Nonprofit Organizations
“23andMe is the largest genotyped research cohort in the world. The scale of this resource provides enormous statistical power for a variety of genetic studies. All research is overseen by an independent Institutional Review Board and 23andMe has implemented robust policies to assure data privacy and revocable consent for participants at any time.”
Ethical practice isn't a policy.
It's how we do science.
Every study we run is built on participant trust, independent oversight and rigorous governance.
Independent IRB oversight
Every study is reviewed and approved by our IRB - an independent nonprofit ethics review board external to 23andMe - before it begins.
The biggest discoveries
happen when we work together.
We make one of the world's largest and most diverse genetic datasets accessible to researchers and partners, so the best scientific minds can answer the questions that matter most to all of us.
As AI transforms how genetic data can be analyzed, the depth and diversity of our cohort becomes more valuable every year. The trusted researchers who engage with our data today are building the tools and models that will define the next generation of medicine.
Be part of a community where every contribution counts.
Join millions of participants.
Hundreds of research partners.
A growing community of supporters.
All moving science and healthcare forward